Pure Global
NCT05343390

Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness

Enhancing HIV-assisted Contact Tracing in Malawi Through Blended Learning: an Implementation Science Study
University of North Carolina, Chapel Hill·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Human Immunodeficiency Virus
Drug/Device/Intervention
Enhanced implementation package
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of North Carolina, Chapel Hill
Location
Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Balaka,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,Machinga,M, Malawi
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2021
End date
Nov 30, 2024
Enrollment
440 participants
Primary outcome

Index client fidelity assessment,Contact client fidelity assessment,Index clients who participate in assisted contact tracing,Contact clients elicited,HIV self-test kits distributed,Contact clients tested,Contact clients living with HIV identified,Cost per contact tested,Cost per person living with HIV diagnosed

Summary

Having health workers assist HIV-infected persons with the recruitment and testing of their
 sexual contacts and biological children is an effective and efficient way of identifying
 additional HIV-infected persons in need of HIV treatment and HIV-uninfected persons in need
 of HIV prevention. However, in Malawi, a country with a generalized HIV epidemic, health
 workers lack the counseling and coordination skills to routinely assist their HIV-infected
 clients with these services. This study will determine how to help health workers to
 effectively and efficiently provide these services to their patients through a set of digital
 capacity-building tools.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHuman immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesAsymptomatic human immunodeficiency virus [HIV] infection status
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05343390
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05343390 through Pure Global AI's free database. This phase not specified trial is sponsored by University of North Carolina, Chapel Hill and is currently Recruiting. The study focuses on Human Immunodeficiency Virus. Target enrollment is 440 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.